US' Ryan White HIV/AIDS Program gets further $1.84bn
This article was originally published in Clinica
The US Department of Health and Human Services (HHS) has released over $1.84bn to its Ryan White HIV/AIDS Program. At least 75% of the funding is for "core medical services", including testing. The programme funds medical and support services for people with insufficient healthcare coverage or finances to manage HIV.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.